Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights

Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms ocurring mostly in the elderly. The clinical outcome of MDS patients is still poor despite progress in treatment approaches. About 90% of patients harbor at least one somatic mutation. This review aimed to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahrabi, Saeid, Khosravi, Abbas, Shahjahani, Mohammad, Rahim, Fakher, Saki, Najmaldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178845/
https://www.ncbi.nlm.nih.gov/pubmed/28058097
http://dx.doi.org/10.4081/oncol.2016.311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178845/
https://www.ncbi.nlm.nih.gov/pubmed/28058097
http://dx.doi.org/10.4081/oncol.2016.311

Ejemplares similares